WaveEdge Capital Advises All Access Ortho on Its Sale to Hawaii Pacific Health Partners

All Access Ortho, a leading Hawaii orthopedic urgent-care clinic group with locations across O'ahu, has been sold to Hawaii Pacific Health Partners, Hawaii's leading healthcare system. Financial terms were not disclosed. AAO principals Dr. Darryl Kan and Dr. Gary Blum will remain involved with Hawaii Pacific Health, supporting expanded orthopedic-service capacity and continuity of care.

Analysis

This is a private, likely immaterial transaction for public markets, but it reinforces a broader provider-market structure: health systems are acquiring specialty access points that steer commercially insured musculoskeletal episodes into owned networks. The economic value is less the urgent-care visit than downstream capture of imaging, ambulatory surgery, physical therapy and elective orthopedic procedures, which can lift system-level revenue per referral while reducing emergency-department leakage.

The second-order pressure falls on independent orthopedic practices and freestanding imaging/ASC operators on O‘ahu, where a dominant system can use employed-physician referral patterns and payer contracting scale to consolidate local volume. Public hospital operators such as HCA Healthcare (HCA), Tenet Healthcare (THC) and Community Health Systems (CYH) have analogous incentives in concentrated markets, but Hawaii's unique geography and limited provider supply make the local playbook difficult to extrapolate into a near-term earnings signal.

No standalone trade is warranted: transaction value, payer mix, clinic volumes, reimbursement rates and integration commitments are undisclosed. Over 6-18 months, this type of acquisition is structurally supportive of scaled systems and potentially negative for independent-provider valuations, but the immediate price impact is nil because neither buyer nor seller is publicly listed. A useful diligence alert is whether Hawaii Pacific Health follows with imaging, ASC, rehabilitation or additional specialty-practice acquisitions; that would indicate deliberate orthopedic episode-of-care consolidation rather than a one-off capacity purchase.

Key Decisions for Investors

• No position based on this event alone; treat as a low-impact private-market data point rather than a catalyst for HCA, THC or CYH.
• Monitor Hawaii provider consolidation over the next 6-12 months, especially acquisitions of ASCs, imaging centers or physical-therapy networks. A multi-asset pattern would strengthen the thesis that local independent specialty-provider exit multiples can rise while referral-dependent operators lose volume.
• For healthcare-services portfolios, maintain a structural preference for scaled, integrated provider platforms over subscale single-specialty assets in concentrated markets; falsify if independent orthopedic groups retain referral share or if payer reimbursement compression offsets downstream volume capture.
• Watch HCA and THC quarterly commentary for employed-physician growth, ambulatory surgery utilization and outpatient orthopedic volumes. Only consider a sector long if those metrics accelerate alongside stable same-facility outpatient margins; absent that evidence, this transaction has no actionable public-equity read-through.